<DOC>
	<DOCNO>NCT02110992</DOCNO>
	<brief_summary>The purpose research study test safety chemotherapy drug call docetaxel focus radiation therapy ( SBRT ) see effect ( good bad ) recurrent head neck cancer surgically removable .</brief_summary>
	<brief_title>Safety Study SBRT Docetaxel Locally Recurrent Second Primary Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Recurrent second primary squamous cell head neck cancer Defined area recurrence image Previous head neck radiation ( RT ) &gt; /= 50 Gy Performance status score 01 Time interval previous RT &gt; /= 9 month Volume disease appropriate protocol treatment Minimum estimate survival &gt; /= 3 month Age &gt; /= 18 Adequate lab Primary tumor salivary gland Original pathology report radiation therapy record available Prior spinal cord dose &gt; 45 Gy Surgery chemotherapy within 4 week Prior invasive malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 3 year ; noninvasive cancer permit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>